Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc

INO

Market Cap$143.84M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Inovio Pharmaceuticals IncInovio Pharmaceuticals Inc-1.2--33%1.80.1
$8.00

Target Price by Analysts

49.8% upsideInovio Pharmaceuticals Target Price DetailsTarget Price
$-1.71

Current Fair Value

132% downside

Overvalued by 132% based on the discounted cash flow analysis.

Share Statistics

Market cap$143.84 Million
Enterprise Value$-21,268,349,778.00
Dividend Yield$0 (0%)
Earnings per Share$-6.09
Beta0.83
Outstanding Shares27,197,802

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.24
PEG0
Price to Sales1.78
Price to Book Ratio0.0
Enterprise Value to Revenue-210.05
Enterprise Value to EBIT0.64
Enterprise Value to Net Income0
Total Debt to Enterprise-0.61
Debt to Equity0.13

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Inovio Pharmaceuticals Inc

CEO: Jong Kim